MetLife (MET) Projected to Post Quarterly Earnings on Wednesday

MetLife (NYSE:MET - Get Free Report) is expected to be posting its Q1 2025 quarterly earnings results after the market closes on Wednesday, April 30th. Analysts expect MetLife to post earnings of $2.04 per share and revenue of $18.06 billion for the quarter.

MetLife (NYSE:MET - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, analysts expect MetLife to post $10 EPS for the current fiscal year and $11 EPS for the next fiscal year.

MetLife Price Performance

Shares of MET traded up $0.76 during mid-day trading on Monday, hitting $75.95. 662,686 shares of the stock were exchanged, compared to its average volume of 3,398,388. The firm has a 50-day moving average of $78.35 and a two-hundred day moving average of $81.78. MetLife has a 52-week low of $65.21 and a 52-week high of $89.05. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The company has a market cap of $51.74 billion, a PE ratio of 12.71, a price-to-earnings-growth ratio of 0.65 and a beta of 0.89.

MetLife Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 10th. Shareholders of record on Tuesday, May 6th will be given a dividend of $0.5675 per share. The ex-dividend date is Tuesday, May 6th. This is an increase from MetLife's previous quarterly dividend of $0.55. This represents a $2.27 dividend on an annualized basis and a yield of 2.99%. MetLife's dividend payout ratio is 38.02%.

Analyst Ratings Changes

Several brokerages have recently weighed in on MET. Barclays reduced their target price on shares of MetLife from $95.00 to $88.00 and set an "overweight" rating on the stock in a research note on Friday, April 11th. Cowen reaffirmed a "buy" rating on shares of MetLife in a research note on Friday, March 7th. Keefe, Bruyette & Woods decreased their price target on MetLife from $98.00 to $95.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. UBS Group increased their target price on MetLife from $94.00 to $98.00 and gave the stock a "buy" rating in a research note on Wednesday, April 2nd. Finally, Wells Fargo & Company cut their price target on shares of MetLife from $97.00 to $91.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $92.46.

Institutional Investors Weigh In On MetLife

An institutional investor recently raised its position in MetLife stock. Brighton Jones LLC raised its holdings in MetLife, Inc. (NYSE:MET - Free Report) by 9.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,240 shares of the financial services provider's stock after buying an additional 351 shares during the quarter. Brighton Jones LLC's holdings in MetLife were worth $347,000 at the end of the most recent reporting period. Institutional investors own 94.99% of the company's stock.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.